+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 2Years - 6Years
All Genders
ID06875167

Evaluating Semi-closed Loop Insulin Pumps in Children Aged 2 to 6 With Type 1 Diabetes to Improve Quality of Life and Blood Sugar Control

Led by Fondation Lenval · Updated on 2025-04-20

20

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying children aged 2 to 6 years with type 1 diabetes to compare the quality of life and diabetes control when using a semi-closed loop automated insulin pump versus other insulin therapies such as open loop pumps or injections. This study focuses on the pediatric population where the semi-closed loop system is newly recognized and reimbursed for this age group in France. The goal is to assess improvements in quality of life and glycemic balance using validated questionnaires and blood sugar control measures. The study observes children who start treatment with the semi-closed loop insulin pump and compares their outcomes to their previous insulin therapies. Each child serves as their own control, allowing evaluation before and after switching to the semi-closed loop system. Quality of life is measured using the PedsQL 4.0 questionnaire at baseline, then at 1 month and 6 months post-implementation. Secondary measures include time in range, HbA1c levels, frequency of hypoglycemic episodes, and time spent in hyperglycemia. Participants will be assessed at three time points before starting the semi-closed loop treatment, at 1 month, and at 6 months after. These evaluations include questionnaires on quality of life and clinical measures of blood sugar control to monitor diabetes balance. The study tracks changes over time to understand how the new system affects daily life and glucose management in young children with type 1 diabetes. Participation lasts at least 6 months, with ongoing observation of both quality of life and glycemic outcomes.

CONDITIONS

Brief Title

Semi-closed Loop Automated Insulin Therapy in the Pediatric Population Aged 2-6 Years With Type 1 Diabetes: Impact on Quality of Life and Glycemic Control

Research Team

A

Aline JOULIE, PHD

V

Valentine FOURNY-SARGHAT, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here